1. Home
  2. TGL vs APM Comparison

TGL vs APM Comparison

Compare TGL & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TGL

Treasure Global Inc.

HOLD

Current Price

$3.65

Market Cap

6.7M

Sector

Technology

ML Signal

HOLD

Logo Aptorum Group Limited

APM

Aptorum Group Limited

N/A

Current Price

$0.83

Market Cap

7.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TGL
APM
Founded
2020
2010
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
7.5M
IPO Year
2022
2018

Fundamental Metrics

Financial Performance
Metric
TGL
APM
Price
$3.65
$0.83
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
38.5K
90.1K
Earning Date
05-14-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,330,557.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$0.65
52 Week High
$58.00
$4.47

Technical Indicators

Market Signals
Indicator
TGL
APM
Relative Strength Index (RSI) 41.57 46.03
Support Level $3.40 $0.73
Resistance Level $9.45 $0.86
Average True Range (ATR) 0.35 0.13
MACD 0.04 -0.02
Stochastic Oscillator 29.99 15.09

Price Performance

Historical Comparison
TGL
APM

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, which targets consumers by providing personalized deals based on their purchase history, location, and preferences. The Company has two reportable segments: payment processing and e-commerce operation in its ZCITY platform, and customized software development service, and the majority of revenue comes from payment processing and e-commerce operation in its ZCITY platform.

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Share on Social Networks: